GridAI Technologies (GRDX) is a US-listed Healthcare company in Biotechnology with a market capitalization of
2M, trading at
.43 on the NASDAQ. This SniperIQ fundamentals page covers GridAI Technologies's valuation, profitability (net margin -11664.8%), revenue (
6,251 in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap
2M
Net Margin-11664.8%
Revenue (FY25)
6,251
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is GridAI Technologies's market cap?
GridAI Technologies (GRDX) has a market capitalization of approximately
2M, trading at
.43 on the NASDAQ. Market cap moves with the live share price.
What is GridAI Technologies's P/E ratio?
GridAI Technologies's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is GridAI Technologies?
GridAI Technologies runs a net profit margin of -11664.8%, a gross margin of -775.6%, and an operating margin of -13264.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does GridAI Technologies generate?
GridAI Technologies reported revenue of
6,251 for fiscal year 2025, with net income of -$6M and earnings per share (EPS) of -4.16. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does GridAI Technologies pay a dividend?
GridAI Technologies does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is GridAI Technologies financially healthy?
GridAI Technologies carries a debt-to-equity ratio of 0.12x and a current ratio of 0.16x, with a market beta of 1.82. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is GridAI Technologies a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For GridAI Technologies (GRDX) the key facts are: market cap
2M, revenue
6,251, 52-week range 1.08-6.929. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track GridAI Technologies's full fundamentals live
Get GridAI Technologies's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.